1. Home
  2. NKTR vs HNVR Comparison

NKTR vs HNVR Comparison

Compare NKTR & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • HNVR
  • Stock Information
  • Founded
  • NKTR 1990
  • HNVR 2008
  • Country
  • NKTR United States
  • HNVR United States
  • Employees
  • NKTR N/A
  • HNVR N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • HNVR Commercial Banks
  • Sector
  • NKTR Health Care
  • HNVR Finance
  • Exchange
  • NKTR Nasdaq
  • HNVR Nasdaq
  • Market Cap
  • NKTR 160.4M
  • HNVR 163.2M
  • IPO Year
  • NKTR 1994
  • HNVR 2022
  • Fundamental
  • Price
  • NKTR $0.74
  • HNVR $22.65
  • Analyst Decision
  • NKTR Strong Buy
  • HNVR Buy
  • Analyst Count
  • NKTR 5
  • HNVR 1
  • Target Price
  • NKTR $5.50
  • HNVR $22.00
  • AVG Volume (30 Days)
  • NKTR 1.4M
  • HNVR 10.3K
  • Earning Date
  • NKTR 03-12-2025
  • HNVR 04-16-2025
  • Dividend Yield
  • NKTR N/A
  • HNVR 1.78%
  • EPS Growth
  • NKTR N/A
  • HNVR N/A
  • EPS
  • NKTR N/A
  • HNVR 1.66
  • Revenue
  • NKTR $98,427,000.00
  • HNVR $63,491,000.00
  • Revenue This Year
  • NKTR N/A
  • HNVR N/A
  • Revenue Next Year
  • NKTR N/A
  • HNVR $16.61
  • P/E Ratio
  • NKTR N/A
  • HNVR $13.46
  • Revenue Growth
  • NKTR 9.21
  • HNVR 5.04
  • 52 Week Low
  • NKTR $0.65
  • HNVR $13.62
  • 52 Week High
  • NKTR $1.93
  • HNVR $27.14
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 36.32
  • HNVR 45.57
  • Support Level
  • NKTR $0.84
  • HNVR $22.29
  • Resistance Level
  • NKTR $0.92
  • HNVR $23.00
  • Average True Range (ATR)
  • NKTR 0.08
  • HNVR 1.04
  • MACD
  • NKTR -0.01
  • HNVR 0.12
  • Stochastic Oscillator
  • NKTR 0.40
  • HNVR 57.37

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.

Share on Social Networks: